highly significantP < 0.0001
Interestingly, mice with MOE- Pten shRNA - Kras G12V tumors, derived from more resistant cells in vitro , showed a modest 4-day increase in median survival; however, a few long-term survivors in the carboplatin-treated group yielded a highly significant response to carboplatin treatment compared with saline control ( P < 0.0001).